Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing

Attitudes toward the patentability of the human embryonic stem cell (hESC) research findings are undergoing dynamic adjustment based on benefit weighing. In the early stage, ethical concerns prevailed: both the United States and China placed restrictions to some extent. As the science and technologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiajv, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365090/
https://www.ncbi.nlm.nih.gov/pubmed/34380021
http://dx.doi.org/10.1016/j.stemcr.2021.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365090/
https://www.ncbi.nlm.nih.gov/pubmed/34380021
http://dx.doi.org/10.1016/j.stemcr.2021.07.005

Ejemplares similares